1. Kounda S, Cojanda L. Candida species – morphology, medical aspects and pathogenic spectrum. European J Molecul Clin Med 2020; 07: 4015-4021.
2. Suddbery P E. The germtubes of C. albicans hyphae and pseudohyphae show different atterns of septin ring localization. Molecular Microbiol 2001; 41: 19-31.
3. Consortium OPATHY and Gabaldon T. Recent trends in molecular diagnostics of yeast infections: from PCR to NGS. FEMS Microbiol Rev 2019; 43: 517–547.
4. Garcia-Rubio R, de Oliveira CH, Rivera J, Trevijano-Contador N. The fungal cell wall: Candida, Cryptococcus, and Aspergillus Species. Front Microbiol 2020; 10: 2993.
5. Ellias D, Hervay N T, Gbelská Y. Ergosterol biosynthesis and regulation impact the antifungal resistance and virulence of Candida spp. Stresses 2024; 4: 641–662.
6. Sautour M, LemaîtreJP, RanjardL, Truntzer C, Basmaciyan L, Depret G, ve ark. Detection and survival of Candida albicans in soils. Environmental DNA 2021; 3:1093. https://doi.org/10.1002/
edn3.230
7. Fakhim H, Vaezi A, Javidnia J, Nasri E, Mahdi D, Diba K. Candida africana vulvovaginitis: Prevalence and geographical distribution. 2020; 30: 100966.
8. Talapko J, Juzbaši M, Matijevi, et al. Candida albicans—The virulence factors and clinical manifestations of infection. J Fungi (Basel) 2021; 7: 79.
9. Caliman Sato M, Emilene Cristine Izu Nakamura Pietro EZ , Costa Alves LM, Kramer A, da Silva Santo PS. Candida auris: a novel emerging nosocomial pathogen – properties, epidemio-
logical situation and infection. GMS Hygiene and Infection Control. 2023; 18: Doc 18.
10. Sengel BE, Berkay BY, Sayın E, Tukenmez Tigen E ,Seydaliyeva A , Cerikcioglu N, Cinel I , Korten V, Sezerman U,ve ark. Nosocomial infection of C. auris in COVID-19 Intensive Care Unit
in Türkiye and Phylogenetic Analysis of Isolates. Mycopathologia 2023; 188:765-773.
11. Hong HY, Yuehong, Xingwei Y. Candida auris infection; diagnosis, and resistance mechanism using high-throughput sequencing technology: a case report and literature review. Front Cell
Infect Microbiol 2023; 13: 1-10.
12. Geremia N, Brugnaro P, Solinas M , Scarparo C, Panes S . Candida auris as an Emergent Public Health Problem: A Current Update on European Outbreaks and Cases. Healthcare. 2023;11:
1-12.
13. Akgül Ö, Çerikçioğlu N. Hypertonic Sabouraud Dextrose Agar as a substrate for differentiation of Candida dubliniensis. Mycopathologia 2009; 167:357-359.
14. Savastano C, Oliveira Silva E, Lemos Gonçalves L, Nery JM, Silva NC, Dias ALT. Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital. Bra-
zilian J Microbiol 2016;47: 367-372.
15. Catavitello C, Onofrillo D, Masciarell G. What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast. Mycoses 2010; 54: 434-
441.30.
16. Cao C, Bing J , Liao G , Nobile CJ , Huang G. Candida haemulonii Species Complex: Emerging fungal pathogens of the Metschnikowiaceae Clade. Zoonosis 2023; 41: 2-6.
17. Pfaller MA, Diekema DJ, Gibbs DL, et al. Candida krusei, a Multidrug-Resistant opportunistic fungal pathogen: Geographic and temporal trends from the ARTEMIS DISK Antifungal Surve-
illance Program, 2001 to 2005. J Clin Microbiol 2008; 46: 515-521.
18. Musso M, Maddalena G, Antonini M. Invasive candidiasis due to Candida norvegensis in a liver transplant patient: case report and literature review. Infect Dis Rep 2014; 6: 5374.
19. Ning YT, Sun TS, Dai RC, Luo ZY, Yu SY, Zhang G, et al. Emergence of multiple fluconazole-resistant Candida parapsilosis sensu stricto clones with persistence and transmission in China. J
Antimicrob Chemother 2024; 79: 128-133.
20. Lin HY, Su BH, Ho MW, Ho CM, Le CY, et al. Reporting an outbreak of Candida pelliculosa (Teleomorph: Wickerhamomyces anomalus) fungemia in a neonatal intensive care unit. J Microbiol
Immunol Infect 2013; 46: 456-62.
21. FanX, Tsui CKM, Chen X, Wan, Liu Z, Yang CX. High prevalence of fluconazole resistant Candida tropicalis among candiduria samples in China: An ignored matter of concern. Front Micro-
biol. 2023; 14:1-6.
22. Du H, Bing J, Xu X, Zheng Q, Hu T, Hao Y, et al. Candida vulturna outbreak caused by cluster of multidrug-resistant strains, China. Emerging Infect Dis 2023; 29: 1425-1428.
23. Pabuççuoğlu U. Kandidiazis. Mikozlar, Patogenez ve Patoloji. İzmir Güven ve Nobel Tıp Kitabevi. 2000; 63.
24. Noumi E, Snoussi M, Noumi I, Saghrouni F, Aouni M, Valenti E. Phenotypic characterization and adhesive properties of vaginal Candida spp. strains provided by the CHU Farhat Hached
(Sousse, Tunisia). Revista Iberoamericana de Micología 2015; 32: 170-179.
25. Yufei H, Tang R, Deng J, Cai T, Ping H, a Wu J, Cao Y. Effects of oestrogen on vulvovaginal candidosis. Mycoses 2022; 65: 4-12.
26. Kozik A , Karkowska-Kuleta J , Zajac D , Bochenska O. Fibronectin-, vitronectin- and laminin-binding proteins at the cell walls of Candida parapsilosis and Candida tropicalis pathogenic
yeasts. BMC Microbiol 2015; 1: 197.
27. Chow EWL, Pang LM, Wang Y. From Jekyll to Hyde: The yeast- Hyphal transition of Candida albicans. Pathogens 2021; 10: 859.
28. Chen H, Zhou X, Ren B, Cheng L. The regulation of hyphae growth in Candida albicans. Virulence 2020; 11: 337–348.
29. Liu H. Co-regulation of pathogenesis with dimorphism and phenotypic switching in Candida albicans, a commensal and a pathogen. Int J Med Microbiol 2002; 292: 299-311.
30. Antony G, Saralaya V, Bhat KG, Shenoy SM, Shivananda PG. Phenotypic switching and its influence on expression of virulence factors by Candida albicans causing candidiasis in human
immunodeficiency virus-infected patients. Indian J Med Microbiol 2007; 25: 241-244.
31. Gokce G, Cerikcioglu N, l Yagci A. Acid proteinase, phospholipase, and biofilm production of Candida species isolated from blood cultures. Mycopathologia 2007; 164 :265-269.
32. Malinovska Z, Conkova E, Vaczi P. Biofilm formation in medically important Candida Species. J. Fungi 2023; 9: 955; 1-6.
33. Uppuluri P, Pierce CG, López-Ribot JL. Candida albicans biofilm formation and its clinical consequences. Future Microbiol 2009; 4:1235–1237.
34. Mathe L, Van Dijck P. Recent insights into Candida albicans biofilm resistance mechanisms. Curr Genet 2013; 59:251–264.
35. Carvalho FM, Teixeira-Santos R, Mergulhão FJM, Gomes L. The Use of Probiotics to Fight Biofilms in Medical Devices: A Systematic Review and Meta-Analysis. Microorganisms 2020; 9: 27.
36. Du H, Zheng Q, Bennett RJ, HuangIDG. Ploidy changes in human fungal pathogens: Going beyond sexual reproduction. PLOS PATHOGENS. 2022; e1010954.
37. Naglik JR, Gaffen SL, Hube B. Candidalysin: discovery and function in Candida albicans infections. Current Opinion in Microbiology 2019; 52:100-109.
38. Zheng NX, Wang Y, Hu DD, Yan L YY. The role of pattern recognition receptors in the innate recognition of Candida albicans. Virulence 2015;6: 347—361.
39. Mancuso G, Mıdırı A, Gerace E, Biondo C. Role of the innate immune system in host defence against fungal infections. European Rev Med Pharmacol Sciences 2022; 26: 1138-1147.
40. Deorukhkar SC. Immunity to candida infection: an overview. MOJ Immunology 2017; 5: 6-8.
41. Taverne-Ghadwal L, Kuhns M, Buhl T , et al. Epidemiology and prevalence of oral candidiasis in HIV patients from Chad in the Post-HAART era. Front Microbiol 2022; 13: 1-12.
42. Kashyap B, Padala SR, Kaur G, Kullaa A. Candida albicans induces oral microbial dysbiosis and promotes oral diseases. Microorganisms 2024; 12: 2138.
43. VilaT, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA. Oral Candidiasis: A disease of opportunity. J Fungi (Basel) 2020; 6: 1-28.
44. Mohammed AA, Lu XI, Mounmin FA. Diagnosis and treatment of esophageal Candidiasis: Current Updates. Hindawi Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1-6.
45. Espinoza ABR, Luján HP, Roberto LR, Arenas R. Balanitis and vulvovaginitis due to Candida albicans. Treated with SUBA-Itraconazole 50 mg. Dermatología Cosmética, Médica Quirúrgica
2019; 17: 192-195.
46. Bouopda Tamo SP. Candida Infections: clinical features, diagnosis and treatment. InfectDis Clin Microbiol 2020; 2: 91-102.
47. Cinicola BL, Uva A, Marzia DM, Zicari AM, Danilo B. Mucocutaneous Candidiasis: Insights Into the Diagnosis and Treatment. The Pediatric Infectious Disease Journal 2024;43: 694-703.
48. Cabbera- Guerro JP, Garcia-Salazar E, Silva GH et al. Candidemia: An update on epidemiology, risk factors, diagnosis, susceptibility, and treatment. Pathogens 2025; 14: 806.
49. Oliva A, Giuseppe De Rosa F, Mikulska M, Pea F, Sanguinetti M, Venditti CTM. Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role
of rezafungin. Expert Rev Anti-infect Therapy 2023; 21: 957-975.
50. Benameur Y, Hammani A, Doghmi K, Abderrahim D. Disseminated candidiasis on FDG-PET/CT. Mol Imaging Radionuclear Ther 2025; 34:165-167.
51. Henao NA, Vagner B. Infections of the central nervous system by Candida.J Infect Dis Immun 2011; 3:79- 84.
52. Konje ET, Kizenga O, Charco N, et al. Five-year cross-sectional study to determine the burden of Candida spp. İnfections of the urinary tract system among patients attending tertiary hospital
in Northwestern Tanzania. BMJ Open 2023; 13: e074833.
53. Barkauskas CE, Perfect JR. Candida pneumoniae: What we know and what we don’t. Intesive Care Medicine 2009; 3: 21-31.
54. Zhidan Zhang Z, Zhu R, Luan Z, Ma X. Risk of invasive candidiasis with prolonged duration of ICU stay: a systematic review and meta-analysis. BMJ Open 2020; 10: e036452.
55. Hankovszky P, Társy D, Nándor Öveges N, Molná Z. Invasive Candida infections in the ICU: diagnosis and therapy. The J Critic Care Med 2015; 1:129-139.
56. Clancy CJ, Nguyen HM. Diagnosing invasive Candidiasis. J Clin Microbiol 2018; 56: e01909-17.
57. Zang Y, Xing H, Bolotnikov G, Krämer A, Kissmann AK, Weil T. Robust Fluorometric Aptamer Assay for Direct and Rapid Detection of clinical Isolates of Candida species. Int J Mol Sci 2024;
25: 3444.
58. Sudhan SS, Sharma P, Sharma M , Shrivastava D. Identification of Candida species in the clinical laboratory: A review of conventional, commercial and molecular techniques. Int J Med Res
Prof 2016; 2: 1-8.
59. Santos GCO, Vasconcelos AJO, Cartágenes MSS, K. D. B. Filho A, Nascimento FRF. Candida infections and therapeutic strategies: Mechanisms of action for traditional and alternative agents.
Front Microbiol 2018; 9:123.
60. Li Y, Hind C, Furner-Pardoe J, Sutton JM, Rahman KM. Antimicrobial Resistance. Understanding the mechanisms of resistance to azole antifungals in Candida species. JAC Antimicrob Resist
2025; 7: dlaf 106 58. Hetta HF, Melhem T, Aljohani HM, et al. Beyond Conventional Antifungals: Combating resistance through novel therapeutic pathways. Pharmaceuticals 2025; 18: 364.
61. Hetta HF, Melhem T, Aljohani HM, et al. Beyond Conventional Antifungals: Combating resistance through novel therapeutic pathways. Pharmaceuticals 2025; 18: 364.
62. Bailie GS. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000; 46: 397–403.
63. Bilal H, Shafiq M, Hou B, Islam R, Khan MN, Khan RU, Zeng Y. Distribution and antifungal susceptibility pattern of Candida species from mainland China: A systematic analysis. Virulence
2022; 13: 1573–1589.
64. Garcia-Effron G. The rising threat of intrinsically resistant Candida species in Argentina. Revista Argentina de Microbiología 2023; 55: 201-209.